Bharathy, N., Svalina, M. N., Settelmeyer, T. P., Cleary, M. M., Berlow, N. E., Airhart, S. D., . . . Keller, C. (2017). Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma. Oncotarget.
Παραπομπή Chicago StyleBharathy, Narendra, et al. "Preclinical Testing of the Glycogen Synthase Kinase-3β Inhibitor Tideglusib for Rhabdomyosarcoma." Oncotarget 2017.
Παραπομπή MLABharathy, Narendra, et al. "Preclinical Testing of the Glycogen Synthase Kinase-3β Inhibitor Tideglusib for Rhabdomyosarcoma." Oncotarget 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.